Skip to content

These Biotechs Are Awaiting FDA Decisions In January

While the most important decisions made by the FDA in December were undoubtedly the Emergency Use Authorizations for two COVID-19 vaccines, the month also saw a number of firsts on the regulatory front, including the authorization of the first test allowing for at-home collection of patient samples to detect both COVID-19 and influenza A and B. Now, today’s article takes a look at the biotech companies awaiting FDA decisions in January. For more, CLICK HERE.